ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

ACS Modifies Pap Test Guidelines

November 27, 1987

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

In Brief: Strohl Leads Oncology Nursing Society; ONS Seeks Nominees For Consumer Panel

June 4, 1999

NCI CTEP Approved Trials For the Month of November

November 29, 2013

New Data Support Claims That Costs Are Higher For Protocol Patients

August 31, 1984

NCI CTEP Approved Trials For the Month of January

January 25, 2013